Crossmark

Increasing levels of Parasutterella in the gut microbiome correlate with improving low-density lipoprotein levels in healthy adults consuming resistant potato starch during a randomised trial

Crossref DOI link: https://doi.org/10.1186/s40795-020-00398-9

Published Online: 2020-12-11

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bush, Jason R. http://orcid.org/0000-0002-6289-5191
Alfa, Michelle J.
License Information

Text and Data Mining valid from 2020-12-01

Version of Record valid from 2020-12-11
More Information

Article History

Received: 29 July 2020

Accepted: 15 November 2020

First Online: 11 December 2020

Ethics approval and consent to participate

: Research and ethics approval and protocol modification approvals were obtained from Health Canada and the University of Manitoba Research Ethics Board before implementation. Health Canada authorized the study (Submission #188517) on June 5, 2013, which was registered on ClinicalTrials.gov (October 11, 2013; NCT01977183). Procedures were followed in accordance with Health Canada and University of Manitoba ethical standards. Participant identifiers were treated in confidence and according to the Personal Health Information Act of Manitoba. Study information was locked in a secured area and information sent for statistical analyses had no participant identifiers. The University of Manitoba Office, Research Quality Management unit independently audited the study.

: Not applicable.

: Jason Bush is employed by and Michelle Alfa provides consulting services for MSP Starch Products Inc., Carberry, MB, Canada, who manufacture MSPrebiotic® resistant potato starch.

Document is current

Any future updates will be listed below